MT 2
$40.00Price
Retatrutide is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. It is studied in laboratory research settings for its role in metabolic pathways, glucose regulation, appetite signaling, and energy expenditure.
